Biogen (BIIB) to Present Findings from MS Cost of Illness Study at ECTRIMS; Will Include Tecfidera Data
Go back to Biogen (BIIB) to Present Findings from MS Cost of Illness Study at ECTRIMS; Will Include Tecfidera Data| Acorda Therapeutics, Inc. (NASDAQ: ACOR) | Delayed: 0.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.66 | 52 Week High | $43.63 | |||
| Open | $0.66 | 52 Week Low | $16.40 | |||
| Day High | $0.66 | P/E | 1.69 | |||
| Day Low | $0.66 | EPS | $0.39 | |||
| Volume | 4 | |||||
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 194.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $194.11 | 52 Week High | $333.65 | |||
| Open | $194.11 | 52 Week Low | $223.02 | |||
| Day High | $194.11 | P/E | 24.85 | |||
| Day Low | $194.11 | EPS | $7.81 | |||
| Volume | 3 | |||||
